| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 664 | 2018 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 227 | 2021 |
| 12-month results from the unblinded phase of the RADIANCE-HTN SOLO trial of ultrasound renal denervation M Azizi, J Daemen, MD Lobo, F Mahfoud, ASP Sharp, RE Schmieder, ... Cardiovascular Interventions 13 (24), 2922-2933, 2020 | 57 | 2020 |
| The phosphate binder ferric citrate and mineral metabolism and inflammatory markers in maintenance dialysis patients: results from prespecified analyses of a randomized … PN Van Buren, JB Lewis, JP Dwyer, T Greene, J Middleton, M Sika, ... American Journal of Kidney Diseases 66 (3), 479-488, 2015 | 56 | 2015 |
| Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial M Azizi, M Saxena, Y Wang, JS Jenkins, C Devireddy, F Rader, ... Jama 329 (8), 651-661, 2023 | 52 | 2023 |
| RADIANCE-HTN Investigators: Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): A multicentre, international, single-blind, randomised, sham … M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... Lancet 391 (10137), 2335-2345, 2018 | 38 | 2018 |
| Patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials AJ Kirtane, ASP Sharp, F Mahfoud, NDL Fisher, RE Schmieder, ... JAMA cardiology 8 (5), 464-473, 2023 | 27 | 2023 |
| A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis R Mehrotra, IB Stanaway, GP Jarvik, M Lambie, J Morelle, J Perl, ... Kidney international 100 (5), 1101-1111, 2021 | 20 | 2021 |
| Ambulatory blood pressure monitoring to predict response to renal denervation: a post hoc analysis of the RADIANCE-HTN SOLO study P Gosse, A Cremer, AJ Kirtane, MD Lobo, M Saxena, J Daemen, Y Wang, ... Hypertension 77 (2), 529-536, 2021 | 20 | 2021 |
| Effects of renal denervation vs sham in resistant hypertension after medication escalation: prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized clinical trial M Azizi, F Mahfoud, MA Weber, ASP Sharp, RE Schmieder, P Lurz, ... JAMA cardiology 7 (12), 1244-1252, 2022 | 19 | 2022 |
| Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial NDL Fisher, AJ Kirtane, J Daemen, F Rader, MD Lobo, M Saxena, ... Journal of Hypertension 40 (2), 221-228, 2022 | 8 | 2022 |
| Light chain podocytopathy mimicking recurrent focal segmental glomerulosclerosis MA Khalighi, MP Revelo, JD Abraham, F Shihab, F Ahmed American Journal of Transplantation 17 (3), 824-829, 2017 | 6 | 2017 |
| Collaborative Study Group: The phosphate binder ferric citrate and mineral metabolism and inflammatory markers in maintenance dialysis patients: Results from prespecified … PN Van Buren, JB Lewis, JP Dwyer, T Greene, J Middleton, M Sika, ... Am J Kidney Dis 66 (3), 479-488, 2015 | 6 | 2015 |
| Patient-level pooled analysis of endovascular ultrasound renal denervation or a sham procedure 6 months after medication escalation: the RADIANCE clinical trial program M Azizi, ASP Sharp, NDL Fisher, MA Weber, MD Lobo, J Daemen, P Lurz, ... Circulation 149 (10), 747-759, 2024 | 4 | 2024 |
| NOVEL ACCESS FOR PERITONEAL DIALYSIS IN AN LVAD PATIENT S Gilligan, M Gregory, J Abraham AMERICAN JOURNAL OF KIDNEY DISEASES 75 (4), 574-575, 2020 | 1 | 2020 |
| Acute kidney injury, necrotizing pancreatitis and nephrocalcinosis: A rare presentation of primary hyperparathyroidism A Sarwal, D Abraham, R Kethineni, N Ramkumar, J Abraham The American Journal of the Medical Sciences 365 (3), 313-314, 2023 | | 2023 |
| ALK INHIBITOR RELATED TUBULAR DYSFUNCTION AND ELECTROLYTE ABNORMALITIES WITH PRESERVED KIDNEY FUNCTION A Sarwal, T Zaman, R Kethineni, N Ramkumar, J Abraham AMERICAN JOURNAL OF KIDNEY DISEASES 79 (4), S62-S63, 2022 | | 2022 |
| ACUTE KIDNEY INJURY, NECROTIZING PANCREATITIS AND NEPHROCALCINOSIS: AN UNCOMMON SEQUELAE OF UNTREATED PRIMARY HYPERPARATHYROIDISM A Sarwal, M Monroe, D Abraham, T Zaman, R Kethineni, N Ramkumar, ... AMERICAN JOURNAL OF KIDNEY DISEASES 79 (4), S62-S62, 2022 | | 2022 |
| 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation (vol 13, pg 2922, 2020) M Azizi, J Daemen, MD Lobo, F Mahfoud, ASP Sharp, RE Schmieder, ... JACC-CARDIOVASCULAR INTERVENTIONS 14 (5), 500-500, 2021 | | 2021 |
| Covid-related renal thrombotic microangiopathy: Role of plasma exchange JJ Kottey, NK Yadav, R Kethineni, S Gilligan, MC Gregory, T Zaman, ... Journal of the American Society of Nephrology, 105-105, 2021 | | 2021 |
